About Ossium Health
Ossium Health is a company based in San Francisco (United States) founded in 2016 by Kevin Caldwell and Erik Woods. It operates as a HealthTech and Professional Services. Ossium Health has raised $125.41 million across 12 funding rounds from investors including HHS, Computer Programs Marketing Group and Vivo Capital. Ossium Health offers products and services including Stem Cell Therapy, Organ Transplant Solutions, and Orthopedic Treatments. Ossium Health operates in a competitive market with competitors including Cellino, Adicet Bio, ImmunoACT, Orca Bio and Nordic Nanovector, among others.
- Headquarter San Francisco, United States
- Founders Kevin Caldwell, Erik Woods
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ossium Health, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$125.41 M (USD)
in 12 rounds
-
Latest Funding Round
$375.11 K (USD), Grant
Aug 14, 2024
-
Investors
HHS
& 8 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ossium Health
Ossium Health offers a comprehensive portfolio of products and services, including Stem Cell Therapy, Organ Transplant Solutions, and Orthopedic Treatments.
Stem cells are developed for blood disease treatment.
Solutions are provided to prevent organ transplant rejection.
Treatments are offered for orthopedic health and recovery.
People of Ossium Health
Unlock access to complete
Funding Insights of Ossium Health
Ossium Health has successfully raised a total of $125.41M across 12 strategic funding rounds. The most recent funding activity was a Grant round of $375.11 thousand completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ossium Health
Ossium Health has secured backing from 9 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include HHS, Computer Programs Marketing Group and Vivo Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and private equity firm
|
Locked | Locked | Locked | |
|
US focused seed and early-stage VC firm
|
Locked | Locked | Locked | |
|
Early-stage ventures are targeted for investment by this VC fund.
|
Locked | Locked | Locked |
Investor details for Ossium Health
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ossium Health
Investment portfolio details for Ossium Health
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ossium Health
Detailed financials for Ossium Health
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ossium Health Comparisons
Peer comparison for Ossium Health
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ossium Health
Ossium Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cellino, Adicet Bio, ImmunoACT, Orca Bio and Nordic Nanovector, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of autologous cell therapies
|
|
| Locked | Locked | Locked |
Immune cell therapies for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Cell therapies for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders
|
|
| Locked | Locked | Locked |
Antibody radionuclide conjugates are developed for haematological cancers.
|
Detailed competitors of Ossium Health
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ossium Health
Complete news archive for Ossium Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ossium Health
Ossium Health was founded in 2016.
Ossium Health is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Kevin Caldwell is the current CEO of Ossium Health. They have also founded this company.
Ossium Health is a funded company, having raised a total of $125.41M across 12 funding rounds to date.
Ossium Health is engaged in bioengineering to enhance human health, vitality, and longevity. The company is recognized for creating a new paradigm in cell therapy by utilizing deceased donor transplant ecosystems to combat blood and immune system diseases. Solutions are developed for hematologic diseases, organ transplant rejection, and orthopedic applications. Partnerships are established with healthcare providers, life science companies, and organ procurement organizations to advance and deploy innovative cell therapies.
Ossium Health's top competitors include Orca Bio, Cellino and Adicet Bio.
Ossium Health offers Stem Cell Therapy, Organ Transplant Solutions, and Orthopedic Treatments.
Ossium Health has 9 investors. Key investors include HHS, Computer Programs Marketing Group, Vivo Capital, First Round Capital, and Manta Ray.